Gene Therapy for Wet AMD Begins Dosing in Cohort 4 of Trial
As reported in Biospace, Adverum Biotechnologies, a gene therapy company focused on clinical stage trials for rare and ocular diseases with unmet needs, has successfully dosed a patient in their…